Dopamine-iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease

被引:4
作者
Buoso, Chiara [1 ,2 ]
Seifert, Markus [2 ,3 ]
Lang, Martin [1 ]
Griffith, Corey M. [4 ]
Andujar, Begon Talavera [4 ]
Rueda, Maria Paulina Castelo [1 ]
Fischer, Christine [2 ]
Doerrier, Carolina [6 ]
Talasz, Heribert [5 ]
Zanon, Alessandra [1 ]
Pramstaller, Peter P. [1 ]
Schymanski, Emma L. [4 ]
Pichler, Irene [1 ]
Weiss, Guenter [2 ,3 ]
机构
[1] Eurac Res, Inst Biomed, I-39100 Bolzano, Italy
[2] Med Univ Innsbruck, Dept Internal Med 2, A-6020 Innsbruck, Austria
[3] Med Univ Innsbruck, Christian Doppler Lab Iron Metab & Anemia Res, A-6020 Innsbruck, Austria
[4] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, L-4362 Belvaux, Luxembourg
[5] Med Univ Innsbruck, Inst Med Biochem, Prot Core Facil, Bioctr Innsbruck, A-6020 Innsbruck, Austria
[6] Oroboros Instruments, A-6020 Innsbruck, Austria
基金
欧盟地平线“2020”;
关键词
Parkinson's disease; Iron; Dopamine; Mitochondrial function; hiPSC-derived neurons; MULTIPLE SYSTEM ATROPHY; ALPHA-SYNUCLEIN; OXIDATIVE STRESS; COMPLEX I; METABOLISM; DYSFUNCTION; NEURONS; CELLS; BRAIN; ACID;
D O I
10.1016/j.nbd.2024.106506
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Imbalances of iron and dopamine metabolism along with mitochondrial dysfunction have been linked to the pathogenesis of Parkinson ' s disease (PD). We have previously suggested a direct link between iron homeostasis and dopamine metabolism, as dopamine can increase cellular uptake of iron into macrophages thereby promoting oxidative stress responses. In this study, we investigated the interplay between iron, dopamine, and mitochondrial activity in neuroblastoma SH-SY5Y cells and human induced pluripotent stem cell (hiPSC)-derived dopaminergic neurons differentiated from a healthy control and a PD patient with a mutation in the alpha-synuclein ( SNCA ) gene. In SH-SY5Y cells, dopamine treatment resulted in increased expression of the transmembrane iron transporters transferrin receptor 1 (TFR1), ferroportin (FPN), and mitoferrin2 (MFRN2) and intracellular iron accumulation, suggesting that dopamine may promote iron uptake. Furthermore, dopamine supplementation led to reduced mitochondrial fitness including decreased mitochondrial respiration, increased cytochrome c control efficiency, reduced mtDNA copy number and citrate synthase activity, increased oxidative stress and impaired aconitase activity. In dopaminergic neurons derived from a healthy control individual, dopamine showed comparable effects as observed in SH-SY5Y cells. The hiPSC-derived PD neurons harboring an endogenous SNCA mutation demonstrated altered mitochondrial iron homeostasis, reduced mitochondrial capacity along with increased oxidative stress and alterations of tricarboxylic acid cycle linked metabolic pathways compared with control neurons. Importantly, dopamine treatment of PD neurons promoted a rescue effect by increasing mitochondrial respiration, activating antioxidant stress response, and normalizing altered metabolite levels linked to mitochondrial function. These observations provide evidence that dopamine affects iron homeostasis, intracellular stress responses and mitochondrial function in healthy cells, while dopamine supplementation can restore the disturbed regulatory network in PD cells.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Mitochondrial homeostasis in Parkinson's disease - a triumvirate rule?
    Ng, Chee-Hoe
    Hang, Liting
    Lim, Kah-Leong
    NEURAL REGENERATION RESEARCH, 2017, 12 (08) : 1270 - 1272
  • [42] Mitochondrial iron dyshomeostasis and its potential as a therapeutic target for Parkinson's disease
    Xiao, Zhixin
    Wang, Xiaoya
    Pan, Xuening
    Xie, Junxia
    Xu, Huamin
    EXPERIMENTAL NEUROLOGY, 2024, 372
  • [43] Parkinson's disease and iron
    Mochizuki, Hideki
    Choong, Chi-Jing
    Baba, Kousuke
    JOURNAL OF NEURAL TRANSMISSION, 2020, 127 (02) : 181 - 187
  • [44] The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease
    Teresa G. Hastings
    Journal of Bioenergetics and Biomembranes, 2009, 41 : 469 - 472
  • [45] Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson's disease
    Mortiboys, Heather
    Aasly, Jan
    Bandmann, Oliver
    BRAIN, 2013, 136 : 3038 - 3050
  • [46] Mitochondrial dynamics and neuronal fate in Parkinson's disease
    Santos, D.
    Cardoso, S. M.
    MITOCHONDRION, 2012, 12 (04) : 428 - 437
  • [47] Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
    Blagov, Alexander
    Postnov, Anton
    Sukhorukov, Vasily
    Popov, Mikhail
    Uzokov, Jamol
    Orekhov, Alexander
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (01):
  • [48] The Interplay of Mitochondrial Bioenergetics and Dopamine Agonists as an Effective Disease-Modifying Therapy for Parkinson's Disease
    Neha
    Mazahir, Iqra
    Khan, Sara Akhtar
    Kaushik, Pooja
    Parvez, Suhel
    MOLECULAR NEUROBIOLOGY, 2024, 61 (10) : 8086 - 8103
  • [49] Mitochondrial abnormalities in the putamen in Parkinson's disease dyskinesia
    Naydenov, Alipi V.
    Vassoler, Fair
    Luksik, Andrew S.
    Kaczmarska, Joanna
    Konradi, Christine
    ACTA NEUROPATHOLOGICA, 2010, 120 (05) : 623 - 631
  • [50] Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activity
    Annesley, Sarah J.
    Lay, Sui T.
    De Piazza, Shawn W.
    Sanislav, Oana
    Hammersley, Eleanor
    Allan, Claire Y.
    Francione, Lisa M.
    Bui, Minh Q.
    Chen, Zhi-Ping
    Ngoei, Kevin R. W.
    Tassone, Flora
    Kemp, Bruce E.
    Storey, Elsdon
    Evans, Andrew
    Loesch, Danuta Z.
    Fisher, Paul R.
    DISEASE MODELS & MECHANISMS, 2016, 9 (11) : 1295 - 1305